Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLeMaitre Vascular, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 6 | $0.48 | $0.53 | $0.50 |
| Q2 2025 | 9 | $0.55 | $0.58 | $0.57 |
| Q3 2025 | 6 | $0.55 | $0.58 | $0.57 |
| Q4 2025 | 7 | $0.65 | $0.68 | $0.66 |
| Q1 2026 | 6 | $0.58 | $0.66 | $0.62 |
| Q2 2026 | 3 | $0.65 | $0.68 | $0.66 |
| Q3 2026 | 3 | $0.62 | $0.65 | $0.64 |
| Q4 2026 | 3 | $0.65 | $0.69 | $0.67 |
| Q1 2027 | 2 | $0.62 | $0.65 | $0.63 |
| Q2 2027 | 2 | $0.68 | $0.72 | $0.70 |
| Q3 2027 | 2 | $0.65 | $0.69 | $0.67 |
| Q4 2027 | 2 | $0.69 | $0.73 | $0.71 |
LeMaitre Vascular, Inc. Earnings Date And Information
LeMaitre Vascular, Inc. last posted its earnings results on Thursday, November 6th, 2025. The company reported $0.62 earnings per share for the quarter, topping analysts' consensus estimates of $0.564 by $0.056. The company had revenue of 61.05 M for the quarter and had revenue of 219.86 M for the year. LeMaitre Vascular, Inc. has generated $2 earnings per share over the last year ($1.93 diluted earnings per share) and currently has a price-to-earnings ratio of 35.91. LeMaitre Vascular, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based on prior year's report dates.
LeMaitre Vascular, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2025 | Q3 2025 | N/A | $0.77 | N/A | $62.17 M | $61.05 M |
| 08/06/2025 | Q2 2025 | N/A | $0.61 | N/A | $62.48 M | $64.23 M |
| 05/08/2025 | Q1 2025 | N/A | $0.49 | N/A | N/A | $59.87 M |
| 02/28/2025 | Q4 2024 | N/A | $0.50 | N/A | N/A | $55.72 M |
| 11/08/2024 | Q3 2024 | N/A | $0.50 | N/A | $53.50 M | $54.82 M |
| 08/08/2024 | Q2 2024 | N/A | $0.53 | N/A | $54.98 M | $55.85 M |
| 05/28/2024 | Q1 2024 | N/A | $0.43 | N/A | $51.50 M | $53.48 M |
| 02/29/2024 | Q4 2023 | N/A | $0.38 | N/A | N/A | $48.88 M |
| 11/07/2023 | Q3 2023 | N/A | $0.34 | N/A | $47.53 M | $47.41 M |
| 08/08/2023 | Q2 2023 | N/A | $0.36 | N/A | $48.08 M | $50.12 M |
| 05/09/2023 | Q1 2023 | N/A | $0.27 | N/A | $43.54 M | $47.08 M |
| 03/01/2023 | Q4 2022 | N/A | $0.26 | N/A | $41.00 M | $40.95 M |
| 11/08/2022 | Q3 2022 | N/A | $0.25 | N/A | $40.01 M | $39.03 M |
| 08/05/2022 | Q2 2022 | N/A | $0.16 | N/A | $41.39 M | $42.11 M |
| 05/10/2022 | Q1 2022 | N/A | $0.28 | N/A | $38.65 M | $39.56 M |
| 02/28/2022 | Q4 2021 | N/A | $0.28 | N/A | $39.64 M | $39.50 M |
| 11/04/2021 | Q3 2021 | N/A | $0.30 | N/A | $39.05 M | $38.37 M |
| 08/05/2021 | Q2 2021 | N/A | $0.40 | N/A | $39.57 M | $40.67 M |
| 05/10/2021 | Q1 2021 | N/A | $0.29 | N/A | $35.19 M | $35.88 M |
| 03/12/2021 | Q4 2020 | N/A | $0.35 | N/A | $35.58 M | $37.55 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
LeMaitre Vascular, Inc. Earnings: FAQ's
LeMaitre Vascular, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based offlast year's report dates.
In the previous quarter, LeMaitre Vascular, Inc. (:LMAT) reported $0.62 earnings per share (EPS) to beat the analysts' consensus estimate of $0.564 by $0.056.
The conference call for LeMaitre Vascular, Inc.'s latest earnings report can be listened to online.
The conference call transcript for LeMaitre Vascular, Inc.'s latest earnings report can be read online.
LeMaitre Vascular, Inc. (:LMAT) has a recorded annual revenue of $219.86 M.
LeMaitre Vascular, Inc. (:LMAT) has a recorded net income of $44.04 M.LeMaitre Vascular, Inc. has generated $1.96 earnings per share over the last four quarters.
LeMaitre Vascular, Inc. (:LMAT) has a price-to-earnings ratio of 35.91 and price/earnings-to-growth ratio is 2.79.